RxSight, Inc. (RXST)
Nasdaq: RXST · Ophthalmic Goods · Aliso Viejo, CA · filing with the SEC since 2002
Who owns RxSight, Inc.
As filed with the SECHolders of 5% or more
4
BlackRock Portfolio Management LLC holds 8.4% of Common Stock, as its SCHEDULE 13G/A filed Oct 27, 2026 says.
Directors and officers
15
report now, of 20 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
BlackRock Portfolio Management LLC
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock · 7.2% in Jul 17, 2026
Millennium Management LLC
SCHEDULE 13G/A · filed Aug 4, 2026 · Common Stock, par value $0.001 per share · 5.4% in Nov 4, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock · 5.8% in Oct 17, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G · filed Aug 19, 2026 · Common Stock, par value $0.001 per share
Artisan Partners Asset Management Inc.
SCHEDULE 13G/A · filed May 13, 2026 · Common Stock · reported falling below 5%, from 5.2% in Feb 3, 2026
Divisadero Street Capital Management, LP
SCHEDULE 13G/A · filed Aug 13, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%, from 6.3% in Apr 8, 2025
Bank of America Corporation
SCHEDULE 13G/A · filed Aug 13, 2025 · Common Stock · reported falling below 5%, from 5.4% in Feb 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Lord, Abbett & Co. LLC
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock · reported falling below 5%
What RXST reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
4sales
0purchases
0sales on a scheduled plan
4people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 25 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Wilterding Mark | Chief Financial Officer | 1 | $100,000 | 0 | 0 | $0 |
| Goldshleger Ilya | Chief Operating Officer | 1 | $0 | 0 | 0 | $0 |
| Weinberg Eric | Chief Business Development Officer | 1 | $0 | 0 | 0 | $0 |
| Kurtz Ronald M Md | Chief Medical Officer | 1 | $0 | 0 | 0 | $0 |